Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
LCTX · NYSE · Biological Products, (No Diagnostic Substances)
$0.82−0.0185 (−2.21%)
Close of Nov 19, 2026, vs Nov 18 · end-of-day, not a live quote
Lineage Cell Therapeutics (LCTX) · oqro.io/stocks/LCTX · printed today. Every figure comes from a public filing, linked on the page online. Not investment advice.
Everything reported about this company, newest first. Each line shows the dates that matter for its source.
Insider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director purchased ~$771K of LCTX shares in the open marketSourceInsider trade · Traded Nov 17, 2026 · Filed Nov 19, 2026
Director purchased ~$26K of LCTX shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 17, 2026
CEO purchased ~$37K of LCTX shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 17, 2026
Director purchased ~$20K of LCTX shares in the open marketSourceInsider trade · Traded Nov 16, 2026 · Filed Nov 16, 2026
CFO purchased ~$17K of LCTX shares in the open marketSourceInsider trade · Traded Jan 27, 2025 · Filed Jan 29, 2025
Director purchased ~$6M of LCTX shares in the open marketSourceInsider trade · Traded Nov 26, 2024 · Filed Nov 26, 2024
CFO purchased ~$8.8K of LCTX shares in the open marketSourceInsider trade · Traded Nov 26, 2024 · Filed Nov 26, 2024
Officer purchased ~$9K of LCTX shares in the open marketSourceInsider trade · Traded Nov 22, 2024 · Filed Nov 25, 2024
Director purchased ~$23K of LCTX shares in the open marketSourceInsider trade · Traded Nov 21, 2024 · Filed Nov 22, 2024
CEO purchased ~$24K of LCTX shares in the open marketSource